Organigram Global Inc. (OGI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OGI Revenue Growth
Revenue Breakdown (FY 2025)
OGI's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
OGI Revenue Analysis (2014–2025)
As of May 8, 2026, Organigram Global Inc. (OGI) generated trailing twelve-month (TTM) revenue of $279.9 million, reflecting explosive growth of +48.6% year-over-year. The most recent quarter (Q1 2026) recorded $63.5 million in revenue, down 20.7% sequentially.
Looking at the longer-term picture, OGI's 5-year compound annual growth rate (CAGR) stands at +16.5%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $186.1 million in 2025, representing a new all-time high.
Revenue diversification analysis shows OGI's business is primarily driven by International Business To Business (69%), Wholesale To Licensed Producers Revenue (24%), and Direct To Patient Medical Revenue (6%). With over half of revenue concentrated in International Business To Business, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CGC (+6.3% YoY), TLRY (+3.0% YoY), and ACB (+12.8% YoY), OGI has underperformed the peer group in terms of revenue growth. Compare OGI vs CGC →
OGI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OGICurrent | $280M | +48.6% | +16.5% | -34.1% | |
 CGC | $269M | +6.3% | -7.6% | -43.5% | |
 TLRY | $1.1B | +3.0% | +22.7% | -277.9% | |
 ACB | $343M | +12.8% | +5.0% | 1.4% | |
 CRON | $193M | +64.4% | +32.9% | -1.5% | |
 SNDL | $946M | +1.1% | +73.1% | -0.5% |
OGI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $186.1M | +16.4% | $6.8M | 3.7% | $-63,405,144 | -34.1% |
| 2024 | $159.8M | +7.1% | $47.5M | 29.7% | $-35,671,000 | -22.3% |
| 2023 | $149.2M | +2.3% | $35.1M | 23.5% | $-242,739,000 | -162.7% |
| 2022 | $145.8M | +84.2% | $31.6M | 21.7% | $-43,151,000 | -29.6% |
| 2021 | $79.2M | -8.8% | $-28,399,000 | -35.9% | $-91,820,000 | -116.0% |
| 2020 | $86.8M | +7.9% | $-56,490,000 | -65.1% | $-145,510,000 | -167.6% |
| 2019 | $80.4M | +547.0% | $48.5M | 60.3% | $5.5M | 6.8% |
| 2018 | $12.4M | +130.6% | $-26,775,000 | -215.4% | $36.4M | 293.0% |
| 2017 | $5.4M | -12.1% | $-3,297,000 | -61.2% | $-11,101,000 | -206.0% |
| 2016 | $6.1M | +521.1% | $5.3M | 86.7% | $1.2M | 20.3% |
See OGI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OGI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOGI — Frequently Asked Questions
Quick answers to the most common questions about buying OGI stock.
Is OGI's revenue growth accelerating or slowing?
OGI revenue is accelerating at +48.6% year-over-year, exceeding the 5-year CAGR of +16.5%. TTM revenue reached $280M. Growth momentum has increased versus prior periods.
What is OGI's long-term revenue growth rate?
Organigram Global Inc.'s 5-year revenue CAGR of +16.5% reflects the sustained expansion pattern. Current YoY growth of +48.6% is above this long-term average.
How is OGI's revenue distributed by segment?
OGI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.